November 15, 2015

GEN Magazine Profiles Biological Dynamics ACE Technology in Featured Article on Clinical Applications of cfDNA in Oncology

November 15, 2015/ Biological Dynamics, Inc/ Guest User

The November 2015 GEN magazine article "Cell-Free DNA Prospecting Starts to Pan Out" by Lisa Heiden, Ph.D. looks at the applications of cell-free DNA (cfDNA) -based diagnostics that are considered to be on the verge of entering the clinical mainstream.

Biological Dynamics - Exosome Tell The Story

Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.

The ExoVerita™ Pro instrument and ExoVita™ Pancreas test described is for Research Use Only. Not for diagnostic purposes.
Biological Dynamics’s Clinical Laboratory is CLIA-certified and CAP accredited.

News

Biological Dynamics - Exosome Tell The Story